Abstract
Despite the marked efficacy of vector-based and mRNA vaccines against the SARS-CoV-2 spike (S) protein, emergence of the variants B.1.1.7 (UK), B.1.351
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
